Aslan Pharmaceuticals

Aslan Pharmaceuticals 是一家在股票代码 ASLN.O (SG) 下上市的公司。

查看带有其 9 名主要高管的组织结构图

Aslan Pharmaceuticals 搜索最多的简介

• Carl Firth, Chief Executive Officer and Director
• Andrew Howden, Chairman of the Board
• Neil Graham, Director

创建提醒
跟踪 Aslan Pharmaceuticals 的高管变动

Aslan Pharmaceuticals 拥有 1,831 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。

Popular M&A news in 药店

• Stemtech and Seacret Direct have announced they will merge  (公布2024十二月5号)..
• Recursion Pharma and Exscientia have merged  (公布2024十一月27号)..
• Stemtech and Seacret Direct have announced they will merge  (公布2024十一月22号)..

药店 行业的其他推荐联系人

• Adare Pharmaceuticals 企业 Kristin Berkinsky - Chief Human Resources Officer
• Sanofi 企业 Julie Van Ongevalle - Executive Vice President and Head of Consumer Healthcare
• Amneal Pharmaceuticals 企业 Paul Meister - Chairman of the Board

了解更多有关药店行业的信息 >

Aslan Pharmaceuticals 的最新新闻稿

• News & Publications - ASLAN Pharmaceuticals
• News & Publications - ASLAN Pharmaceuticals
• News & Publications - ASLAN Pharmaceuticals
• News & Publications - ASLAN Pharmaceuticals

关于 Aslan Pharmaceuticals 的社交媒体

• Aslan Pharmaceuticals 在 维基百科、谷歌新闻 和 雅虎财经
• Aslan Pharmaceuticals 在 LinkedIn、叽叽喳喳 和 YouTube

通过电子邮件联系联系该企业高管，包括 Carl Firth

致电Aslan Pharmaceuticals，电话：+65 65...

查看组织结构图

Register to receive your alert

报告错误